Brief: Hepion Pharmaceuticals Further Strengthens Board With Appointments Of Accomplished Biopharmaceutical Executives, Mr. Anand Reddi And Dr. Kaouthar Lbiati
28/06/2022 13:36
June 28 (Reuters) - Hepion Pharmaceuticals Inc HEPA.O :
* HEPION PHARMACEUTICALS FURTHER STRENGTHENS BOARD WITH
APPOINTMENTS OF ACCOMPLISHED BIOPHARMACEUTICAL EXECUTIVES, MR.
ANAND REDDI AND DR. KAOUTHAR LBIATI
Source text for Eikon: ID:nGNX75h45g
Further company coverage: HEPA.O
Recent news on Hepion Pharmaceuticals
See all newsBrief: Hepion Pharmaceuticals Executes Binding Letter Of Intent With New Day Diagnostics To Commercialize Diagnostic Tests For Celiac Disease, Respiratory Multiplex, H. Pylori And Hcc
Brief: Hepion Pharma In-Licenses Diagnostic Tests from New Day Diagnostics- SEC Filing
Brief: Hepion Pharmaceuticals Announces Termination Of Merger Agreement With Pharma Two B
Brief: Hepion Pharmaceuticals Issues Letter to Shareholders Urging Support for Proposed Merger with Pharma Two B
Brief: Pharma Two B Plans To Go Public Via Merger With Hepion Pharmaceuticals, Concurrent $11.5 Mln Private Placement